[Protein S3 fragments neighboring mRNA during elongation and translation termination on the human ribosome]. 2008

Iu S Khaĭrulina, and M V Molotkov, and K N Bulygin, and D M Graĭfer, and A G Ven'yaminova, and L Iu Frolova, and J Stahl, and G G Karpova
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, 630090 Russia.

Protein S3 fragments were determined that crosslink to modified mRNA analogues in positions +5 to +12 relative to the first nucleotide in the P-site binding codon in model complexes mimicking states of ribosomes at the elongation and translation termination steps. The mRNA analogues contained a Phe codon UUU/UUC at the 5'-termini that could predetermine the position of the tRNA(Phe) on the ribosome by the location of P-site binding and perfluorophenylazidobenzoyl group at a nucleotide in various positions 3' of the UUU/UUC codon. The crosslinked S3 protein was isolated from 80S ribosomal complexes irradiated with mild UV light and subjected to cyanogen bromide-induced cleavage at methionine residues with subsequent identification of the crosslinked oligopeptides. An analysis of the positions of modified oligopeptides resulting from the cleavage showed that, in dependence on the positions of modified nucleotides in the mRNA analogue, the crosslinking sites were found in the N-terminal half of the protein (fragment 2-127) and/or in the C-terminal fragment 190-236; the latter reflects a new peculiarity in the structure of the mRNA binding center in the ribosome, unknown to date. The results of crosslinking did not depend on the type of A-site codon or on the presence of translation termination factor eRF1.

UI MeSH Term Description Entries
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010441 Peptide Chain Elongation, Translational A process of GENETIC TRANSLATION, when an amino acid is transferred from its cognate TRANSFER RNA to the lengthening chain of PEPTIDES. Chain Elongation, Peptide, Translational,Protein Biosynthesis Elongation,Protein Chain Elongation, Translational,Protein Translation Elongation,Translation Elongation, Genetic,Translation Elongation, Protein,Translational Elongation, Protein,Translational Peptide Chain Elongation,Biosynthesis Elongation, Protein,Elongation, Genetic Translation,Elongation, Protein Biosynthesis,Elongation, Protein Translation,Elongation, Protein Translational,Genetic Translation Elongation,Protein Translational Elongation
D010443 Peptide Chain Termination, Translational A process of GENETIC TRANSLATION whereby the terminal amino acid is added to a lengthening polypeptide. This termination process is signaled from the MESSENGER RNA, by one of three termination codons (CODON, TERMINATOR) that immediately follows the last amino acid-specifying CODON. Chain Termination, Peptide, Translational,Protein Biosynthesis Termination,Protein Chain Termination, Translational,Protein Translation Termination,Translation Termination, Genetic,Translation Termination, Protein,Translational Peptide Chain Termination,Translational Termination, Protein,Biosynthesis Termination, Protein,Genetic Translation Termination,Protein Translational Termination,Termination, Genetic Translation,Termination, Protein Biosynthesis,Termination, Protein Translation,Termination, Protein Translational
D010454 Peptide Termination Factors Proteins that are involved in the peptide chain termination reaction (PEPTIDE CHAIN TERMINATION, TRANSLATIONAL) on RIBOSOMES. They include codon-specific class-I release factors, which recognize stop signals (TERMINATOR CODON) in the MESSENGER RNA; and codon-nonspecific class-II release factors. Termination Release Factor,Factor, Termination Release,Factors, Peptide Termination,Release Factor, Termination,Termination Factors, Peptide
D003062 Codon A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE). Codon, Sense,Sense Codon,Codons,Codons, Sense,Sense Codons
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012269 Ribosomal Proteins Proteins found in ribosomes. They are believed to have a catalytic function in reconstituting biologically active ribosomal subunits. Proteins, Ribosomal,Ribosomal Protein,Protein, Ribosomal
D012270 Ribosomes Multicomponent ribonucleoprotein structures found in the CYTOPLASM of all cells, and in MITOCHONDRIA, and PLASTIDS. They function in PROTEIN BIOSYNTHESIS via GENETIC TRANSLATION. Ribosome
D012346 RNA, Transfer, Amino Acyl Intermediates in protein biosynthesis. The compounds are formed from amino acids, ATP and transfer RNA, a reaction catalyzed by aminoacyl tRNA synthetase. They are key compounds in the genetic translation process. Amino Acyl tRNA,Transfer RNA, Amino Acyl,tRNA-Amino Acyl,Amino Acyl T RNA,Acyl tRNA, Amino,Acyl, tRNA-Amino,tRNA Amino Acyl,tRNA, Amino Acyl
D014466 Ultraviolet Rays That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants. Actinic Rays,Black Light, Ultraviolet,UV Light,UV Radiation,Ultra-Violet Rays,Ultraviolet Light,Ultraviolet Radiation,Actinic Ray,Light, UV,Light, Ultraviolet,Radiation, UV,Radiation, Ultraviolet,Ray, Actinic,Ray, Ultra-Violet,Ray, Ultraviolet,Ultra Violet Rays,Ultra-Violet Ray,Ultraviolet Black Light,Ultraviolet Black Lights,Ultraviolet Radiations,Ultraviolet Ray

Related Publications

Iu S Khaĭrulina, and M V Molotkov, and K N Bulygin, and D M Graĭfer, and A G Ven'yaminova, and L Iu Frolova, and J Stahl, and G G Karpova
January 2021, Computational and structural biotechnology journal,
Iu S Khaĭrulina, and M V Molotkov, and K N Bulygin, and D M Graĭfer, and A G Ven'yaminova, and L Iu Frolova, and J Stahl, and G G Karpova
April 2017, Nature protocols,
Iu S Khaĭrulina, and M V Molotkov, and K N Bulygin, and D M Graĭfer, and A G Ven'yaminova, and L Iu Frolova, and J Stahl, and G G Karpova
May 2014, eLife,
Iu S Khaĭrulina, and M V Molotkov, and K N Bulygin, and D M Graĭfer, and A G Ven'yaminova, and L Iu Frolova, and J Stahl, and G G Karpova
August 2009, Nature structural & molecular biology,
Iu S Khaĭrulina, and M V Molotkov, and K N Bulygin, and D M Graĭfer, and A G Ven'yaminova, and L Iu Frolova, and J Stahl, and G G Karpova
February 2014, Biochemical Society transactions,
Iu S Khaĭrulina, and M V Molotkov, and K N Bulygin, and D M Graĭfer, and A G Ven'yaminova, and L Iu Frolova, and J Stahl, and G G Karpova
January 2007, Seikagaku. The Journal of Japanese Biochemical Society,
Iu S Khaĭrulina, and M V Molotkov, and K N Bulygin, and D M Graĭfer, and A G Ven'yaminova, and L Iu Frolova, and J Stahl, and G G Karpova
June 2022, Biophysical chemistry,
Iu S Khaĭrulina, and M V Molotkov, and K N Bulygin, and D M Graĭfer, and A G Ven'yaminova, and L Iu Frolova, and J Stahl, and G G Karpova
September 2019, eLife,
Iu S Khaĭrulina, and M V Molotkov, and K N Bulygin, and D M Graĭfer, and A G Ven'yaminova, and L Iu Frolova, and J Stahl, and G G Karpova
April 2004, The Journal of biological chemistry,
Iu S Khaĭrulina, and M V Molotkov, and K N Bulygin, and D M Graĭfer, and A G Ven'yaminova, and L Iu Frolova, and J Stahl, and G G Karpova
August 2011, RNA (New York, N.Y.),
Copied contents to your clipboard!